Compare Wockhardt with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs NEULAND LABS - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT NEULAND LABS WOCKHARDT/
NEULAND LABS
 
P/E (TTM) x -84.4 45.4 - View Chart
P/BV x 1.9 3.4 54.4% View Chart
Dividend Yield % 0.0 0.1 2.0%  

Financials

 WOCKHARDT   NEULAND LABS
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
NEULAND LABS
Mar-20
WOCKHARDT/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs1,012754 134.3%   
Low Rs532247 214.9%   
Sales per share (Unadj.) Rs355.9594.5 59.9%  
Earnings per share (Unadj.) Rs-60.312.6 -477.1%  
Cash flow per share (Unadj.) Rs-46.837.0 -126.3%  
Dividends per share (Unadj.) Rs0.012.00 0.5%  
Dividend yield (eoy) %00.4 0.3%  
Book value per share (Unadj.) Rs257.8553.4 46.6%  
Shares outstanding (eoy) m110.6312.83 862.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.20.8 257.6%   
Avg P/E ratio x-12.839.6 -32.3%  
P/CF ratio (eoy) x-16.513.5 -122.1%  
Price / Book Value ratio x3.00.9 331.0%  
Dividend payout %015.8 -0.1%   
Avg Mkt Cap Rs m85,3796,421 1,329.7%   
No. of employees `0006.31.3 487.8%   
Total wages/salary Rs m9,3711,236 758.4%   
Avg. sales/employee Rs Th6,295.05,949.4 105.8%   
Avg. wages/employee Rs Th1,498.3963.8 155.5%   
Avg. net profit/employee Rs Th-1,066.3126.4 -843.4%   
INCOME DATA
Net Sales Rs m39,3697,627 516.2%  
Other income Rs m1,20239 3,094.7%   
Total revenues Rs m40,5717,666 529.2%   
Gross profit Rs m181,019 1.8%  
Depreciation Rs m1,495313 478.0%   
Interest Rs m2,555216 1,184.3%   
Profit before tax Rs m-2,830529 -534.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257367 70.0%   
Profit after tax Rs m-6,669162 -4,114.3%  
Gross profit margin %013.4 0.3%  
Effective tax rate %-9.169.4 -13.1%   
Net profit margin %-16.92.1 -797.1%  
BALANCE SHEET DATA
Current assets Rs m33,7965,152 656.0%   
Current liabilities Rs m26,9173,576 752.6%   
Net working cap to sales %17.520.7 84.6%  
Current ratio x1.31.4 87.2%  
Inventory Days Days79105 75.5%  
Debtors Days Days8991 98.2%  
Net fixed assets Rs m39,6643,969 999.5%   
Share capital Rs m553129 428.8%   
"Free" reserves Rs m27,9686,971 401.2%   
Net worth Rs m28,5227,100 401.7%   
Long term debt Rs m21,731774 2,808.7%   
Total assets Rs m81,62012,310 663.1%  
Interest coverage x-0.13.5 -3.1%   
Debt to equity ratio x0.80.1 699.2%  
Sales to assets ratio x0.50.6 77.8%   
Return on assets %-5.03.1 -164.2%  
Return on equity %-23.42.3 -1,024.1%  
Return on capital %-7.79.5 -81.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,8075,187 189.1%   
Fx outflow Rs m1,7891,593 112.3%   
Net fx Rs m8,0193,594 223.1%   
CASH FLOW
From Operations Rs m684573 119.4%  
From Investments Rs m6,302-487 -1,294.7%  
From Financial Activity Rs m-7,695-55 14,041.4%  
Net Cashflow Rs m-66433 -2,036.8%  

Share Holding

Indian Promoters % 74.5 36.3 205.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 63.7 3.6%  
FIIs % 7.7 0.0 -  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 63.7 24.2%  
Shareholders   67,757 12,705 533.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  PFIZER  ALKEM LABORATORIES  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Mutual Fund Buying Activity in February, Easy Trip Planners IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended their day on a flat note yesterday. At the closing bell yesterday, the BSE Sensex stood higher by 35 points (up 0.1%).

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

Charge Your Portfolio with this Smallcap Proxy Play on India's EV Revolution(Profit Hunter)

Mar 5, 2021

This could be the biggest wealth creator of the decade.

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Mar 8, 2021 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS